| Financial Year |
March 31 2023 |
| Monetary Funds |
434,099,884.49 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
25,426,212.64 |
| Accounts Receivable |
586,420,553.36 |
| Advances to Suppliers |
45,630,669.77 |
| Other Receivables |
34,825,875.70 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
464,430,658.16 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
28,099,833.22 |
| Total Current Assets |
1,824,285,897.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
103,161,959.41 |
| Investment Properties |
1,532,667.59 |
| Fixed Assetes |
582,162,732.34 |
| Under-construction Projects |
6,138,527.98 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
237,868,629.87 |
| R&D expenses |
55,483,215.17 |
| Goodwill |
89,242,421.94 |
| Long-Term Deferred and Prepaid Expenses |
28,608,387.51 |
| Deferred Income Tax Assets |
36,766,707.72 |
| Other Non-Current Assets |
3,610,646.00 |
| Sub-Total of Non-Current Assets |
1,308,965,905.64 |
| Total Assets |
3,133,251,803.48 |
| Short-Term Loans |
183,061,378.13 |
| Trading Financial liabilities |
-- |
| Notes Payable |
252,864,404.09 |
| Accounts Payable |
593,067,336.98 |
| Accounts Received In Advance |
170,497.39 |
| Employee Compensation Payable |
27,358,398.04 |
| Taxes Payable |
11,327,404.58 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,948,621.87 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
18,567,217.36 |
| Other Current Liabilities |
24,942,670.12 |
| Sub-Total of Current Liabilities |
1,175,791,805.56 |
| Long-term Loans |
9,800,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
19,653,186.06 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,607,290.74 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
44,296,542.03 |
| Total Liabilities |
1,220,088,347.59 |
| Paid-In Capital(Or Share Stock) |
542,369,011.00 |
| Capital Surplus |
735,050,715.76 |
| Surplus Reserve |
113,799,532.00 |
| LESS:Treasury Stock |
100,111,232.40 |
| Undistributed Profits |
554,502,350.59 |
| Minority Stockholder's Interest |
81,828,728.94 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,831,334,726.95 |
| Owner's Equity（Stockholder's Equity） |
1,913,163,455.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,133,251,803.48 |
